Sildenafil/Tadalafil Recall: Mojo Max Fusion XXX
Announced 2026-03-11 · FDA
FDA recalls Mojo Max Fusion XXX capsules marketed without an approved NDA/ANDA and containing undeclared sildenafil (13.1 mg per capsule) and tadalafil (13.8 mg per capsule). The recall covers all lots with expiration date 12/31/2027 and nationwide distribution in the United States. No corrective action is specified in the recall notice.
| Brand | Mohamed Hagar |
|---|---|
| Product | Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0 |
| Reason | Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule). |
| Severity | critical |
| Units affected | 125 |
| Distribution | U.S. Nationwide |
| Agency | FDA |
| Recall / campaign no. | ALL LOTS, exp 12/31/2027 |
WHAT YOU SHOULD DO
- Stop using Mojo Max Fusion XXX immediately.
- Dispose of the product or return it to the place of purchase for a refund.
- Refer to the recall notice for instructions and contact the distributor for more information; seek medical advice if you have health concerns after exposure.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.